• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Pitanium Limited

    9/15/25 4:15:26 PM ET
    $PTNM
    Package Goods/Cosmetics
    Consumer Discretionary
    Get the next $PTNM alert in real time by email
    6-K 1 form6-k.htm 6-K

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 6-K

     

    REPORT OF FOREIGN PRIVATE ISSUER

    PURSUANT TO RULE 13a-16 OR 15d-16

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month of September 2025

     

    Commission File Number: 001-42669

     

    PITANIUM LIMITED

    (Registrant’s Name)

     

    30F, Gravity, 29 Hing Yip Street,

    Kwun Tong, Kowloon, Hong Kong

    (Address of principal executive offices)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    Information Contained in this Form 6-K Report

     

    Pitanium Limited (“Pitanium”) and its subsidiary (collectively, the “Company”) is furnishing this Form 6-K to provide six-month interim financial statements.

     

    Special Note Regarding Forward-Looking Statements

     

    Statements in this current report with respect to the Company’s current plans, estimates, strategies, beliefs and other statements that are not historical facts are forward-looking statements about the future performance of the Company. Forward-looking statements include, but are not limited to, those statements using words such as “believe,” “expect,” “plans,” “strategy,” “prospects,” “forecast,” “estimate,” “project,” “anticipate,” “aim,” “intend,” “seek,” “may,” “might,” “could” or “should,” and words of similar meaning in connection with a discussion of future operations, financial performance, events, or conditions. From time to time, oral or written forward-looking statements may also be included in other materials released to the public. These statements are based on management’s assumptions, judgments, and beliefs in light of the information currently available to it. The Company cautions investors that a number of important risks and uncertainties could cause actual results to differ materially from those discussed in the forward-looking statements, including but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the U.S. Securities and Exchange Commission. Therefore, investors should not place undue reliance on such forward-looking statements. Actual results may differ significantly from those set forth in the forward-looking statements.

     

    All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements that may accompany the forward-looking statements. In addition, the Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

     

    Financial Statements and Exhibits.

     

    Exhibits:

     

    Exhibit No.   Description
    99.1   Unaudited Interim Consolidated Financial Statements as of March 31, 2025 and for the Six Months Ended March 31, 2025 and 2024
    99.2   Operating and Financial Review in Connection with the Unaudited Interim Consolidated Financial Statements for the Six Months Ended March 31, 2025 and 2024

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: September 15, 2025 Pitanium Limited
         
      By: /s/ Ying Yeung Wong
      Name: Ying Yeung Wong
      Title: Chief Executive Officer and Director

     

     

    Get the next $PTNM alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PTNM

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $PTNM
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Halts Pitanium Limited

    NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading is halted in Pitanium Limited (NASDAQ:PTNM) for additional information requested from the company. Previously, the Securities and Exchange Commission effected a trading suspension in PTNM from 04:00:00 on October 6, 2025 to 23:59:00 on October 17, 2025. The last sale price of the company's ordinary shares was $10.39.  More information about the SEC's order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104165.pdf. Trading will remain halted until Pitanium Limited has fully satisfied Nasdaq's request for additional information. For news and additional inform

    10/18/25 10:00:00 AM ET
    $NDAQ
    $PTNM
    Investment Bankers/Brokers/Service
    Finance
    Package Goods/Cosmetics
    Consumer Discretionary

    $PTNM
    SEC Filings

    View All

    SEC Form 6-K filed by Pitanium Limited

    6-K - Pitanium Ltd (0002046573) (Filer)

    10/7/25 5:15:02 PM ET
    $PTNM
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Pitanium Limited

    6-K - Pitanium Ltd (0002046573) (Filer)

    9/15/25 4:15:26 PM ET
    $PTNM
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 6-K filed by Pitanium Limited

    6-K - Pitanium Ltd (0002046573) (Filer)

    6/16/25 4:10:26 PM ET
    $PTNM
    Package Goods/Cosmetics
    Consumer Discretionary